Criteria Bio Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
NRG Therapeuticsnrgtherapeutics.cominSep 2025 · $67M
NRG Therapeutics is a clinical-stage neuroscience drug discovery company developing disease-modifying, oral small-molecule medicines that target mitochondrial function via inhibition of the mitochondrial permeability transition pore.
BiotechHealthtechLongevity
Co-investorsM VenturesNovartis Venture FundSV Health InvestorsBritish Business BankDementia Discovery Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.